Marujo, FPelham, SJFreixo, JCordeiro, AIMartins, CCasanova, JLLei, WTPuel, ANeves, JF2022-05-092022-05-092021J Clin Immunol . 2021 Aug;41(6):1376-1379http://hdl.handle.net/10400.17/4067Inborn errors of the IL-17-mediated signaling have been associated with chronic mucocutaneous candidiasis (CMC). We describe a patient with CMC, atopic dermatitis, enamel dysplasia, and recurrent parotitis harboring a novel compound heterozygous mutation of TRAF3IP2, leading to autosomal recessive ACT1 deficiency and deficient IL-17 signaling.engACT1Candida sppIL-17TRAF3IP2Chronic mucocutaneous candidiasisHDE PEDjournal article10.1007/s10875-021-01026-2